We are live on ! Find out more
DARE icon

Dare Bioscience
DARE

24 hedge funds and large institutions have $2.39M invested in Dare Bioscience in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 3

0.57% more ownership

Funds ownership: 8.93% → 9.51% (+0.57%)

1% less capital invested

Capital invested by funds: $2.43M → $2.39M (-$34.9K)

4% less funds holding

Funds holding: 25 → 24 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
24
Holders Change
-1
Holders Change %
-4%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
8
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$123K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$54.6K
3
AE
AMH Equity
New York
+$44.4K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$10.1K
5
Renaissance Technologies
Renaissance Technologies
New York
+$5.9K

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$51.7K
2
UBS Group
UBS Group
Switzerland
-$32K
3
TRCT
Tower Research Capital (TRC)
New York
-$602
4
JP Morgan Chase
JP Morgan Chase
New York
-$6
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$949K +$123K +39,703 +14%
AE
2
AMH Equity
New York
$475K +$44.4K +14,302 +10%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$277K +$10.1K +3,252 +4%
Renaissance Technologies
4
Renaissance Technologies
New York
$204K +$5.9K +1,900 +3%
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$168K +$54.6K +17,582 +43%
State Street
6
State Street
Massachusetts
$68K – – –
UBS Group
7
UBS Group
Switzerland
$63.8K -$32K -10,302 -32%
BlackRock
8
BlackRock
New York
$49K – – –
Commonwealth Equity Services
9
Commonwealth Equity Services
Massachusetts
$48K +$155 +50 +0.3%
Northern Trust
10
Northern Trust
Illinois
$43.5K +$230 +74 +0.5%
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$31K – – –
AF
12
Allworth Financial
California
$5K – – –
TRCT
13
Tower Research Capital (TRC)
New York
$4.17K -$602 -194 -12%
IA
14
IFS Advisors
Kansas
$2.75K – – –
SS
15
SBI Securities
Japan
$1.66K – – –
Bank of America
16
Bank of America
North Carolina
$252 +$12 +4 +5%
MG
17
Mather Group
Illinois
$243 – – –
EWA
18
EverSource Wealth Advisors
Alabama
$121 – – –
Osaic Holdings
19
Osaic Holdings
Arizona
$72 – – –
JP Morgan Chase
20
JP Morgan Chase
New York
$55 -$6 -2 -10%
CSC
21
Caldwell Sutter Capital
California
$49 – – –
Morgan Stanley
22
Morgan Stanley
New York
$20 – – –
CPG
23
Cornerstone Planning Group
New Jersey
$6 – – –
PFG
24
Putney Financial Group
California
$3 – – –
Jane Street
25
Jane Street
New York
– -$51.7K -16,584 Closed

DARE Hedge Fund Activity: Q1 2025 in Review

24 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q1 2025, worth a combined $2.39M — down 1.4% from $2.43M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of DARE and 0 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 8 added.

The largest buyer was Vanguard Group, adding an estimated $123K. The largest seller was Jane Street, exiting entirely with an estimated $51.7K sold.

  • 24 institutional investors held Dare Bioscience (DARE) as of Q1 2025, down from 25 in Q4 2024.
  • Funds reported $2.39M of Dare Bioscience stock for Q1 2025, down 1.4% quarter-over-quarter.
  • 0 funds opened new Dare Bioscience positions in Q1 2025 and 1 closed out, a net change of -1 holder.
  • The largest Dare Bioscience buyer in Q1 2025 was Vanguard Group, an estimated $123K added.
  • The largest Dare Bioscience seller in Q1 2025 was Jane Street, an estimated $51.7K sold.

Based on aggregated 13F filings for Q1 2025.